These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11092613)

  • 21. Neither lymphotoxin alpha nor lymphotoxin beta receptor expression is required for biogenesis of lymphoid aggregates or differentiation of natural killer cells in the pregnant mouse uterus.
    Kather A; Chantakru S; He H; Minhas K; Foster R; Markert UR; Pfeffer K; Croy BA
    Immunology; 2003 Mar; 108(3):338-45. PubMed ID: 12603600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
    Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K
    J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor.
    Rennert PD; James D; Mackay F; Browning JL; Hochman PS
    Immunity; 1998 Jul; 9(1):71-9. PubMed ID: 9697837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
    Hehlgans T; Männel DN
    J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection.
    Roach DR; Briscoe H; Saunders B; France MP; Riminton S; Britton WJ
    J Exp Med; 2001 Jan; 193(2):239-46. PubMed ID: 11208864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and expression analysis of the murine lymphotoxin beta gene.
    Pokholok DK; Maroulakou IG; Kuprash DV; Alimzhanov MB; Kozlov SV; Novobrantseva TI; Turetskaya RL; Green JE; Nedospasov SA
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):674-8. PubMed ID: 7846035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lymphotoxin pathway: beyond lymph node development.
    McCarthy DD; Summers-Deluca L; Vu F; Chiu S; Gao Y; Gommerman JL
    Immunol Res; 2006; 35(1-2):41-54. PubMed ID: 17003508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.
    Kretschmer C; Jones DB; Morrison K; Schlüter C; Feist W; Ulmer AJ; Arnoldi J; Matthes J; Diamantstein T; Flad HD
    Am J Pathol; 1990 Aug; 137(2):341-51. PubMed ID: 2386200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects.
    Medvedev AE; Espevik T; Ranges G; Sundan A
    J Biol Chem; 1996 Apr; 271(16):9778-84. PubMed ID: 8621658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy.
    Grom AA; Murray KJ; Luyrink L; Emery H; Passo MH; Glass DN; Bowlin T; Edwards C
    Arthritis Rheum; 1996 Oct; 39(10):1703-10. PubMed ID: 8843861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells.
    Elewaut D; Brossay L; Santee SM; Naidenko OV; Burdin N; De Winter H; Matsuda J; Ware CF; Cheroutre H; Kronenberg M
    J Immunol; 2000 Jul; 165(2):671-9. PubMed ID: 10878339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
    Rennert PD; Browning JL; Hochman PS
    Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members.
    Voon DC; Subrata LS; Karimi M; Ulgiati D; Abraham LJ
    J Immunol; 2004 Apr; 172(7):4332-41. PubMed ID: 15034048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function.
    Alexopoulou L; Pasparakis M; Kollias G
    J Exp Med; 1998 Aug; 188(4):745-54. PubMed ID: 9705956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.
    Pasparakis M; Alexopoulou L; Grell M; Pfizenmaier K; Bluethmann H; Kollias G
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6319-23. PubMed ID: 9177215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors.
    Silva-Santos B; Pennington DJ; Hayday AC
    Science; 2005 Feb; 307(5711):925-8. PubMed ID: 15591166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.